Clinical Trial Update: Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients

View source ↗

Summary

This document provides an update on how multiple sclerosis patients respond to dalfampridine-ER treatment in a completed clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine-ER (dalfampridine)

Snippet

Sponsor: Mount Sinai Rehabilitation Hospital | Conditions: Multiple Sclerosis | Status: COMPLETED